In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

AstraZeneca PLC Balance Sheet Statement - Assets

As of 31 Dec 2021, The total current assets of AstraZeneca PLC (LSE:AZN) was around $26,244,000,000 which consisted of $6,329,000,000 of Cash, $8,983,000,000 of Inventory and $8,795,000,000 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in USD

Current assets
Total assets

The latest balance sheet of AstraZeneca PLC also showed $10,171,000,000 of Property Plant Equipment and $19,997,000,000 of Good will. Also there were $42,387,000,000 of Intangible assets and $5,302,000,000 of Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $105,363,000,000.

AstraZeneca PLC Balance Sheet Statement - Liabilities

AZN's latest annual results shows the balance sheet has $2,824,000,000 of Accounts Payable. Also there were $2,248,000,000 of Short/Long term debt, $29,717,000,000 of Long term debt, $4,520,000,000 of Other Current liabilities and $22,594,000,000 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
Current liabilities
Total liabilities

As per the 31 Dec 2021's annual report of AstraZeneca PLC, the total liabilities were $66,076,000,000.

AZN Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of AstraZeneca PLC showed the total stock holder equity was $39,268,000,000 which consisted of $387,000,000 of Common stocks, $3,644,000,000 of Retained earnings and $111,000,000 of Other stock holder equity.

AZN Balance Sheet Statement History

Following table shows the history of balance sheet for AstraZeneca PLC (AZN).

31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Cash 6.33B 7.83B 5.37B 4.83B
Net Receivables 8.79B 5.65B 5.18B 4.84B
Inventory 8.98B 4.02B 3.19B 2.89B
Total Current Assets 26.24B 19.54B 15.56B 15.59B
Property Plant Equipment 10.17B 8.92B 8.34B 7.42B
Good Will 20B 11.85B 11.67B 11.71B
Intangible Assets 42.39B 20.95B 20.83B 21.96B
Other Assets 5.3B 4.28B 3.47B 3B
Deferred Long Term Asset Charges 4.33B 3.44B 2.72B 2.38B
Total Assets 105.36B 66.73B 61.38B 60.65B
Accounts Payable 2.82B 2.35B 1.77B 1.72B
Short/Long Term Debt 2.25B 1.57B 1.63B 1.03B
Other Current Liabilities 4.52B 5.85B 4.9B 3.73B
Long Term Debt 29.72B 19.8B 17.89B 19.2B
Other Liabilities 13.01B 10.49B 10.28B 11.11B
Total Current Liabilities 22.59B 20.31B 18.12B 16.29B
Total Liabilities 66.08B 51.09B 46.78B 46.61B
Common Stock 387M 328M 328M 317M
Retained Earnings 3.64B 6.44B 5B 7.69B
Treasury Stock 111M 881M -143M 34M
Other Stockholder Equity 111M 881M -143M 34M
Total Stockholder Equity 39.27B 15.62B 13.13B 12.47B
Net Tangible Assets -23.12B -17.17B -19.37B -21.2B

AstraZeneca PLC (LSE:AZN) Balance Sheet Statement FAQ

1. How much Cash AstraZeneca PLC has on their balance sheet?

As of 31 Dec 2021, AstraZeneca PLC (LSE:AZN) has $6,329,000,000 of Cash.

2. What's the long term debt of AstraZeneca PLC?

As per the latest Balance sheet of AstraZeneca PLC (LSE:AZN), it has $29,717,000,000 of Long term debt.

3. How much share holder equity does AstraZeneca PLC has?

The AstraZeneca PLC (LSE:AZN)'s balance sheet shows that it has $39,268,000,000 of Total stock holder equity.